Clinical Trial Update: A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 clinical trial evaluating long-term treatment with etavopivat in people with Sickle Cell Disease or Thalassemia, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Thalassemia

Drugs mentioned

• Etavopivat (Etavopivat)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Sickle Cell Disease, Thalassemia | Phase 3 | Status: RECRUITING